Human telomere, oncogenic promoter and 5′-UTR G-quadruplexes: Diverse higher order DNA and RNA targets for cancer therapeutics Journal Article


Authors: Patel, D. J.; Phan, A. T.; Kuryavyi, V.
Article Title: Human telomere, oncogenic promoter and 5′-UTR G-quadruplexes: Diverse higher order DNA and RNA targets for cancer therapeutics
Abstract: Guanine-rich DNA sequences can form G-quadruplexes stabilized by stacked G-G-G-G tetrads in monovalent cation-containing solution. The length and number of individual G-tracts and the length and sequence context of linker residues define the diverse topologies adopted by G-quadruplexes. The review highlights recent solution NMR-based G-quadruplex structures formed by the four-repeat human telomere in K+ solution and the guanine-rich strands of c-myc, c-kit and variant bcl-2 oncogenic promoters, as well as a bimolecular G-quadruplex that targets HIV-1 integrase. Such structure determinations have helped to identify unanticipated scaffolds such as interlocked G-quadruplexes, as well as novel topologies represented by double-chain-reversal and V-shaped loops, triads, mixed tetrads, adenine-mediated pentads and hexads and snap-back G-tetrad alignments. The review also highlights the recent identification of guanine-rich sequences positioned adjacent to translation start sites in 5′-untranslated regions (5′-UTRs) of RNA oncogenic sequences. The activity of the enzyme telomerase, which maintains telomere length, can be negatively regulated through G-quadruplex formation at telomeric ends. The review evaluates progress related to ongoing efforts to identify small molecule drugs that bind and stabilize distinct G-quadruplex scaffolds associated with telomeric and oncogenic sequences, and outlines progress towards identifying recognition principles based on several X-ray-based structures of ligand-G-quadruplex complexes. © 2007 The Author(s).
Keywords: unclassified drug; oncoprotein; promoter region; sequence analysis; review; nonhuman; antineoplastic agent; neoplasms; telomere; gene targeting; imatinib; stem cell factor receptor; antineoplastic activity; enzyme activity; oncogenes; rna; oncogene; dna; double stranded dna; 5' untranslated region; daunorubicin; telomerase reverse transcriptase; dna structure; protein structure; dna determination; enzyme localization; human immunodeficiency virus 1; g-quadruplexes; rna sequence; 5' untranslated regions; promoter regions (genetics); 2.6 diamidodianthraquinone; 5,20, tetrakis n methyl 4 pyridyl; anthraquinone derivative; braco 19; guanosine phosphate; integrase inhibitor; monovalent cation; porphyrin; regulatory dna sequence; dna repeat expansion
Journal Title: Nucleic Acids Research
Volume: 35
Issue: 22
ISSN: 0305-1048
Publisher: Oxford University Press  
Date Published: 2007-12-01
Start Page: 7429
End Page: 7455
Language: English
DOI: 10.1093/nar/gkm711
PUBMED: 17913750
PROVIDER: scopus
PMCID: PMC2190718
DOI/URL:
Notes: --- - "Cited By (since 1996): 196" - "Export Date: 17 November 2011" - "CODEN: NARHA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dinshaw J Patel
    478 Patel